New treatment for heart failure to support thousands of Australian patients

20 December 2021 - From 1 January 2022, tens of thousands of Australians with symptomatic heart failure will have access to ...

Read more →

Medicine agency recommends listing of life-saving drugs for Australian men with deadly forms of prostate cancer

17 December 2021 - Prostate Cancer Foundation of Australia has welcomed recommendations by Australia’s Pharmaceutical Benefits Advisory Committee to list ...

Read more →

Recommendations made by the PBAC - November 2021

17 December 2021 - The recommendations from the November 2021 PBAC meeting are now available. ...

Read more →

Price disclosure 2022 April cycle outcomes summary

10 December 2021 - The summary of price disclosure price reductions for the 2022 April Cycle has now been published ...

Read more →

Biosimilar follitropin alfa on the PBS - information for health care professionals and patients

7 December 2021 - A biosimilar brand of follitropin alfa (Ovaleap) was listed on the PBS on 1 December 2021.  ...

Read more →

PBS in review (2021)

5 December 2021 - We review the new medicines listed on the PBS in 2021. ...

Read more →

Agenda for the December 2021 PBAC intracycle meeting

3 December 2021 - The agenda for the December 2021 PBAC intracycle meeting is now available. ...

Read more →

Strengthening patient access to new medicines through new landmark Bill

2 December 2021 - Australians will see improved access to new and innovative medicines, vaccines and treatments as a landmark ...

Read more →

DoH revises agenda for March 2022 PBAC meeting twice in one day!

2 December 2021 - Version 3 came and went quickly; the current version (version 4) makes no reference to the ...

Read more →

Schedule of Pharmaceutical Benefits - 1 December 2021

1 December 2021 - The December 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...

Read more →

New treatment for Australians with leukaemia

28 November 2021 - From 1 December 2021, Australians with acute myeloid leukaemia will have access to a new treatment option ...

Read more →

Here we go again - version 2.0

26 November 2021 - The agenda for the March 2022 PBAC agenda has been revised within 48 hours of publication. ...

Read more →

Additional insights from the agenda for the March 2022 PBAC meeting

26 November 2021 - More insights from the MAESTrO Team. ...

Read more →

Insights from the agenda (version 1.0) for the March 2022 PBAC meeting

26 November 2021 - Some insights from the MAESTrO Team. ...

Read more →

Preparing for health care’s new frontier: Committee releases major report on reforming the process for new medicines and health technology

25 November 2021 - A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant ...

Read more →